Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-१.५५%
१,०७४.६३
-१६.८८
-१.५५%
—१,०९१.५११,०९०.४०१,०९०.४०१,०७४.५०——
SIXC
Communications
SIXC
Communications
SIXC
-०.४०%
६०७.७०
-२.४१
-०.४०%
—६१०.११६१०.११६१०.२९६०६.१७——
SIXE
Energy
SIXE
Energy
SIXE
+०.७९%
१,२४७.७६
+९.७८
+०.७९%
—१,२३७.९८१,२३७.८३१,२५२.४११,२२५.०३——
SIXI
Industrials
SIXI
Industrials
SIXI
-१.१०%
१,७२५.४९
-१९.२२
-१.१०%
—१,७४४.७११,७४०.९५१,७४७.२९१,७२१.५७——
SIXM
Financials
SIXM
Financials
SIXM
-०.६६%
६३५.९४
-४.२४
-०.६६%
—६४०.१८६३९.९२६४३.१९६३४.७३——
SIXR
Staples
SIXR
Staples
SIXR
-१.०२%
८४०.९०
-८.६८
-१.०२%
—८४९.५८८४५.२७८५१.६८८३९.४७——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.५७%
२१६.२४
-१.२४
-०.५७%
—२१७.४८२१७.४८२१८.१६२१५.५१——
SIXT
Technology
SIXT
Technology
SIXT
+०.२५%
३,२६८.८२
+८.१३
+०.२५%
—३,२६०.६९३,२७३.३६३,२८७.८१३,२४०.७८——
SIXU
Utilities
SIXU
Utilities
SIXU
-०.३७%
९३८.९५
-३.५०
-०.३७%
—९४२.४५९३९.३९९४८.८०९३३.९८——
SIXV
Health care
SIXV
Health care
SIXV
-०.३७%
१,४६१.३१
-५.४९
-०.३७%
—१,४६६.८०१,४६४.७०१,४६७.१९१,४५८.३६——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-०.७३%
२,३७९.९७
-१७.५३
-०.७३%
—२,३९७.५०२,३९५.०३२,४१२.०१२,३७०.६४——
EW:NYSE
Edwards Lifesciences Corp
US$ ८३.२५
-०.८७%
(-०.७३) 1D
मे ४, १५:५३:४५ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EW...
Open
US$ ८३.६६
High
US$ ८४.६४
Low
US$ ८३.१८
Mkt. cap
४७.९९ अरब
Avg. vol.
५३.५२ लाख
Volume
१९.३० लाख
P/E ratio
४४.३७
52-wk high
US$ ८७.८९
52-wk low
US$ ७२.३०
EPS
US$ १.८८
Beta
०.८७
Shares outstanding
५७.६५ करोड
No. of employees
१६ हजार
News stories
From sources across the web
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility completed in 2021 in Limerick, Ireland. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees१६ हजार
Founded१९५८
Headquartersइरविन, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websiteedwards.com
Last report
२०२६ अप्रिल २३
Fiscal Period
Q1 2026
Normalized EPS / Estimate
०.७८/ (०.७३ est.)USD
+७.३३%beat
Revenue / Estimate
१.६५ अरब/ (१.६० अरब est.)USD
+३.३१%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
१.५३ अरब
१.५५ अरब
१.५७ अरब
१.६५ अरब
Cost of goods sold
३४.४४ करोड
३४.५२ करोड
३४.३० करोड
३६.२६ करोड
Cost of revenue
३४.४४ करोड
३४.५२ करोड
३४.३० करोड
३६.२६ करोड
Research and development expenses
२७.६२ करोड
२८.०७ करोड
२६.७७ करोड
२६.३३ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५०.२० करोड
५१.४६ करोड
६०.१२ करोड
५२.२२ करोड
Operating expense
७५.६९ करोड
७८.२८ करोड
८५.४६ करोड
७७.१३ करोड
Total operating expenses
१.१० अरब
१.१३ अरब
१.२० अरब
१.१३ अरब
Operating income
४३.०९ करोड
४२.५१ करोड
३७.२० करोड
५१.४७ करोड
Other non operating income
-४.९९ करोड
११.०० लाख
२३.०० लाख
६३.०० लाख
EBT including unusual items
४०.०२ करोड
३४.८४ करोड
९.०४ करोड
४५.९० करोड
EBT excluding unusual items
४०.०९ करोड
४४.४५ करोड
४६.४० करोड
५५.४५ करोड
Income tax expense
६.४३ करोड
५.६१ करोड
२.६२ करोड
७.८३ करोड
Effective tax rate
१६.०७%
१६.१०%
२८.९८%
१७.०६%
Other operating expenses
-२.१३ करोड
-१.२५ करोड
-१.४३ करोड
-१.४२ करोड
Net income
३३.३२ करोड
२९.११ करोड
९.१२ करोड
३८.०७ करोड
Net profit margin
२१.७५%
१८.७४%
५.८१%
२३.०९%
Earnings per share
०.६७
०.६७
०.५८
०.७८
Interest and investment income
१.८४ करोड
१.६७ करोड
११.४२ करोड
३.३५ करोड
Interest expense
-
-
-२.०४ करोड
-
Net interest expenses
१.८४ करोड
१.६७ करोड
९.३८ करोड
३.३५ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
४६.९० करोड
४६.४३ करोड
४१.४७ करोड
५५.३८ करोड
Gain or loss from assets sale
-
-
-३.३९ करोड
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer